Uremic Toxins Affecting Cardiovascular Calcification: A Systematic Review

Area of Science:

• Nephrology
• Cardiology
• Toxicology

Background:

• Cardiovascular calcification is a major complication in chronic kidney disease (CKD), increasing patient morbidity and mortality.
• Uremic toxins, accumulating due to impaired kidney function, are implicated in the pathogenesis of cardiovascular calcification.
• Understanding the specific roles of uremic toxins is crucial for developing targeted therapies.

Purpose of the Study:

• To systematically review the impact of various uremic toxins on cardiovascular calcification.
• To identify specific uremic toxins that induce or inhibit calcification.
• To elucidate the mechanisms by which uremic toxins affect cardiovascular calcification.

Main Methods:

• A systematic literature search was conducted to identify studies investigating uremic toxins and cardiovascular calcification.
• Studies included in vitro and animal models examining the effects of 41 identified uremic toxins.
• Mechanistic pathways, including inflammation, oxidative stress, and cellular changes, were analyzed.

Main Results:

• Of 41 studied uremic toxins, 16 demonstrated a calcification-inducing effect.
• Three specific guanidino compounds (asymmetric dimethylarginine, symmetric dimethylarginine, guanidinosuccinic acid) showed in vitro calcification inhibitory effects.
• Mechanisms involve inflammation, oxidative stress, smooth muscle cell differentiation/apoptosis, and alkaline phosphatase activity.

Conclusions:

• The majority of uremic toxins investigated promote cardiovascular calcification, underscoring their detrimental role in CKD.
• Middle molecular weight and protein-bound uremic toxins show an increasing effect on calcification, suggesting improved dialysis strategies are needed.
• Further research into the effects of a broader range of uremic toxins and their modifications on cardiovascular calcification is warranted.